Global nasal spray market expected to reach USD 59.41 billion by 2032, driven by increasing demand and innovations

From GlobeNewswire: 2025-06-25 09:10:00

The global Nasal Spray Market was valued at USD 29.92 billion in 2024 and is projected to reach USD 59.41 billion by 2032, with a CAGR of 8.97%. The U.S. market alone is expected to reach USD 18.07 billion by 2032, driven by increasing cases of respiratory disorders and innovations in formulations.

Nasal sprays are favored for various applications, from congestion relief to emergency medication administration, due to their non-invasive nature. They are transforming treatment paradigms and are widely used for delivering drugs directly into the bloodstream or brain, bypassing the gastrointestinal tract.

The market is witnessing high demand for nasal sprays due to rapid regulatory approvals, increased awareness, and ease of self-administration. Pediatric and geriatric patients prefer needle-free alternatives, and nasal sprays are also being adopted for vaccine delivery and emergency medication administration.

The corticosteroids segment dominated the market in 2024, with over 38% market volume share, due to their wide usage in treating inflammation-related nasal problems. Nasal allergies accounted for 45.6% market share in 2024, driven by rising levels of allergens and urban air pollution.

North America led the global market in 2024, with the U.S. being the largest market shareholder. Asia Pacific is expected to register the fastest growth, fueled by increasing pollution levels and rising respiratory disorder diagnosis rates in countries like India and China.

Recent developments include Lupin’s generic Atrovent nasal spray receiving U.S. FDA clearance and Corstasis Therapeutics filing NDA for Bumetanide nasal spray for pulmonary edema treatment. Stay updated with our detailed Nasal Spray Market Analysis & Outlook Report 2024-2032 for in-depth insights and trends.



Read more at GlobeNewswire: Nasal Spray Market Size to Reach USD 59.41 Billion by 2032,